Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionPinnacle Associates Ltd
Latest Disclosed Ownership117,746 shares
Latest Disclosed Value $ 7,141,284
Pinnacle Associates Ltd reports 0.27% decrease in ownership of BRM / Bristol-Myers Squibb Company

On April 21, 2026 - Pinnacle Associates Ltd filed a 13F-HR form disclosing ownership of 117,746 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $6,172,245 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 118,070 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.27% during the quarter. The current value of the position is $5,585,282 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 117,746 -324 -0.27 7,141 12.14 0.0915
2026-02-05 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 118,070 9,997 9.25 6,369 30.65 0.0817
2025-11-13 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 108,073 -9,396 -8.00 4,874 -10.35 0.0647
2025-08-04 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 117,469 -6,817 -5.48 5,438 -28.27 0.0787
2025-05-06 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 124,286 4,203 3.50 7,580 11.62 0.1111
2025-02-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 120,083 -145,958 -54.86 6,792 -50.25 0.0921
2024-10-25 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 266,041 70,905 36.34 13,651 68.44 0.2321
2024-07-30 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 195,136 -6,121 -3.04 8,104 -25.75 0.1269
2024-04-26 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 201,257 -64,784 -24.35 10,914 -20.04 0.1720
2024-01-19 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 266,041 -144,388 -35.18 13,651 -42.70 0.2297
2023-10-24 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 410,429 -10,368 -2.46 23,821 -11.48 0.4428
2023-07-27 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 420,797 156,281 59.08 26,910 46.78 0.4669
2023-05-05 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 264,516 -890 -0.34 18,334 -3.99 0.3750
2023-02-01 2022-12-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 265,406 -2,715 -1.01 19,096 0.18 0.4161
2023-01-25 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 265,664 -2,457 21,051 0.0004
2022-11-01 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 268,121 -7,007 -2.55 19,061 -10.03 0.4375
2022-08-02 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 275,128 1,905 0.70 21,185 6.17 0.4620
2022-05-05 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 273,223 -18,257 -6.26 19,953 9.79 0.3532
2022-02-02 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 291,480 -15,060 -4.91 18,174 0.20 0.3135
2021-10-19 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 306,540 -13,232 -4.14 18,138 -15.11 0.3344
2021-08-02 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 319,772 -12,172 -3.67 21,367 1.96 0.3863
2021-05-12 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 331,944 -14 -0.00 20,956 1.77 0.3996
2021-01-26 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 331,958 -22,539 -6.36 20,591 -3.66 0.4181
2020-10-23 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 354,497 19,299 5.76 21,373 8.44 0.5076
2020-08-14 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 335,198 -518 -0.15 19,710 5.33 0.4860
2020-05-13 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 335,716 30,334 9.93 18,713 -4.54 0.5685
2020-02-03 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 305,382 66,303 27.73 19,602 61.68 0.4292
2019-11-08 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 239,079 4,355 1.86 12,124 13.89 0.2856
2019-08-05 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 234,724 -3,541 -1.49 10,645 -6.36 0.2493
2019-05-10 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 238,265 9,816 4.30 11,368 -4.27 0.2568
2019-02-05 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 228,449 -12,170 -5.06 11,875 -20.50 0.3066
2018-11-09 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 240,619 -4,925 -2.01 14,938 9.94 0.3099
2018-08-08 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 245,544 1,171 0.48 13,588 -12.09 0.2796
2018-05-11 2018-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 244,373 610 0.25 15,457 3.47 0.3029
2018-02-12 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 243,763 9,157 3.90 14,938 -0.11 0.2870
2017-11-13 2017-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 234,606 -37,618 -13.82 14,954 -1.41 0.2757
2017-08-09 2017-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 272,224 -17,830 -6.15 15,168 -3.84 0.2915
2017-05-09 2017-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 290,054 27,793 10.60 15,773 2.91 0.3012
2017-02-10 2016-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 262,261 4,379 1.70 15,327 10.23 0.3092
2016-11-14 2016-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 257,882 1,474 0.57 13,905 -26.27 0.2789
2016-08-15 2016-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 256,408 -421 -0.16 18,859 14.95 0.4064
2016-05-13 2016-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 256,829 -5,522 -2.10 16,406 -9.09 0.3509
2016-02-11 2015-12-31 13F/A-1 BRISTOL MYERS SQUIBB COM 110122108 262,351 -1,425 -0.54 18,047 15.57 0.3786
2016-02-09 2015-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 262,351 -1,425 18,047 0.3856
2015-11-10 2015-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 263,776 -5,111 -1.90 15,616 -12.72 0.3455
2015-08-12 2015-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 268,887 -8,382 -3.02 17,892 0.04 0.3322
2015-05-15 2015-03-31 13F Bristol-Myers Squibb COM 110122108 277,269 13,594 5.16 17,884 14.90 0.3337
2015-02-12 2014-12-31 13F Bristol-Myers Squibb COM 110122108 263,675 1,570 0.60 15,565 16.03 0.3052
2014-11-12 2014-09-30 13F Bristol-Myers Squibb COM 110122108 262,105 16,377 6.66 13,415 12.54 0.2732
2014-08-14 2014-06-30 13F Bristol-Myers Squibb COM 110122108 245,728 48,796 24.78 11,920 16.51 0.2327
2014-05-14 2014-03-31 13F Bristol-Myers Squibb COM 110122108 196,932 -27,899 -12.41 10,231 -14.38 0.1995
2014-02-12 2013-12-31 13F Bristol-Myers Squibb COM 110122108 224,831 -4,160 -1.82 11,950 12.76 0.2333
2013-11-14 2013-09-30 13F Bristol-Myers Squibb COM 110122108 228,991 2,866 1.27 10,598 4.87 0.2192
2013-08-13 2013-06-30 13F Bristol-Myers Squibb COM 110122108 226,125 226,125 10,106 0.2271
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.